Literature DB >> 181932

Serum and pancreatic immunoreactive insulin (IRI) and proinsulin-like component (PLC), serum IRI and PLC response to different stimuli in normal subjects and organic hyperinsulinism.

G K Rastogi, R Sialy, M K Sinha, R Dash, J S Chopra, R N Kataria.   

Abstract

The serum levels of total immunoreactive insulin (IRI) and proinsulin-like component (PLC) in the fasting state and following the administration of insulin secretagogues in 5 patients with organic hyperinsulinism and age and sex matched normal subjects are reported. Diagnosis of organic hyperinsulinism could be established in all instances on the basis of the inappropriately high total serum IRI levels for the corresponding blood glucose values; such an abnormal relationship was not seen in normal subjects, and was further enhanced by insulin secretagogues. Unrestrained insulin secretion in organic hyperinsulinism was enhanced following the administration of glucose, tolbutamide, glucagon or amino acids; the last 2 stimuli are known to be ineffective in causing insulin secretion in the presence of hypoglycemia in normal subjects. Four patints had insulinomas and one probably had islet cell hyperplasia or abnormal function of islet cells. Chromatography of serum IRI to quantitate PLC is a useful adjunct to the diagnosis of organic hyperinsulinism as in the fasting state the proportion of PLC is always elevated, above the normal range of 5-22%. Following the administration of insulin secretagogues there was pronounced increase in total serum IRI in organic hyperinsulinism but the proportion of PLC generally decreased, suggesting thereby that mojor increase in IRI was due to release of stored granular IRI which is known to have a low proportion of PLC.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 181932     DOI: 10.1007/bf02581104

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  18 in total

1.  Proinsulin, insulin, and C-peptide concentrations in human portal and peripheral blood.

Authors:  D L Horwitz; J I Starr; M E Mako; W G Blackard; A H Rubenstein
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

Review 2.  Alpha- and beta-cell interrelationships in health and disease.

Authors:  R H Unger
Journal:  Metabolism       Date:  1974-06       Impact factor: 8.694

3.  Plasma proinsulin in patients with functioning pancreatic islet cell tumors.

Authors:  B M Sherman; S Pek; S S Fajans; J C Floyd; J W Conn
Journal:  J Clin Endocrinol Metab       Date:  1972-08       Impact factor: 5.958

Review 4.  Progress report. Diagnosis of insulinoma.

Authors:  V Marks
Journal:  Gut       Date:  1971-10       Impact factor: 23.059

5.  Significance of human plasma insulin Sephadex fractions.

Authors:  S J Goldsmith; R S Yalow; S A Berson
Journal:  Diabetes       Date:  1969-12       Impact factor: 9.461

6.  Proinsulin content of pancreas in human fetuses of healthy mothers.

Authors:  G K Rastogi; J Letarte; T R Fraser
Journal:  Lancet       Date:  1970-01-03       Impact factor: 79.321

7.  Immunoreactive insulin content of 203 pancreases from foetuses of healthy mothers.

Authors:  G K Rastogi; J Letarte; T R Fraser
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

8.  Human serum proinsulin.

Authors:  F Melani; A H Rubenstein; D F Steiner
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

9.  Proinsulin secretion by a pancreatic beta-cell adenoma. Proinsulin and C-peptide secretion.

Authors:  F Melani; W G Ryan; A H Rubenstein; D F Steiner
Journal:  N Engl J Med       Date:  1970-10-01       Impact factor: 91.245

10.  Proinsulin and insulin content of subcellular fractions from an islet adenoma.

Authors:  A W Lindall; E T Wong; R L Sorenson; M W Steffes
Journal:  J Clin Endocrinol Metab       Date:  1972-04       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.